Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease Treated with Nebulized Arformoterol Following a Respiratory Event

Background: Long-acting beta2-agonists (LABAs), with or without inhaled corticosteroids (ICSs), delivered by handheld inhalers or nebulizers are recommended as maintenance therapy in chronic obstructive pulmonary disease (COPD). This study evaluated exacerbations, health resource utilization (HRU),...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Chronic Obstr Pulm Dis
Hlavní autoři: Navaie, Maryam, Celli, Bartolome R., Xu, Zhun, Cho-Reyes, Soojin, Dembek, Carole, Gilmer, Todd P.
Médium: Artigo
Jazyk:Inglês
Vydáno: COPD Foundation Inc 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7006702/
https://ncbi.nlm.nih.gov/pubmed/31483988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15326/jcopdf.6.4.2019.0127
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky